Using an Online Platform to Help Adults with Lung, Colorectal, Breast, or Prostate Cancer Track Medication Safety at Home

What this Trial Is About

Researchers are evaluating a self-monitoring platform designed to help patients with lung, colorectal, breast, and prostate cancer track medication safety events and concerns. This study focuses on patients receiving oral anticancer agents who face challenges managing complex treatment plans, potential toxicities, and interactions at home. The goal is to support patients in becoming vigilant partners in managing their medication and reporting issues to clinicians during care transitions. Participants use an online platform to record their experiences and concerns related to their cancer medications over six months. They may also receive educational materials and follow-up contacts from nurse practitioners as needed. After the initial six-month period, patients are encouraged to continue using the self-monitoring platform for an additional six months if they wish. During the study, researchers will assess usability, usefulness, ease of use, patient engagement, medication self-management ability, symptom distress, quality of life, and healthcare utilization including emergency room visits and hospitalizations. Data will be gathered through surveys, interviews, electronic health record reviews, and system usage tracking up to twelve months. The study aims to understand how this platform supports medication safety and patient activation in cancer care.

A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients